Evidence map›Paper›PMID 36732240›Full record

ArticleThe Journal of the Acoustical Society of America2023

Noise-induced hearing disorders: Clinical and investigational tools.

Colleen G Le Prell, Odile H Clavier, Jianxin Bao

Open access · bronzeAbstract readEditorial
In one paragraph

Article in The Journal of the Acoustical Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Colleen G Le PrellDepartment of Speech, Language, and Hearing Science, University of Texas at Dallas, Richardson, Texas 75080, USA.ORCID 0000-0002-6161-3033
Odile H ClavierCreare LLC, Hanover, New Hampshire 03755, USA.ORCID 0000-0003-4439-4120
Jianxin BaoGateway Biotechnology Inc., St. Louis, Missouri 63132, USA.
Creare (United States) · USThe University of Texas at Dallas · US

Funding

Targeting multiple signaling pathways for tinnitus prevention and treatmentR44DC018759 · NIDCD · GATEWAY BIOTECHNOLOGY, INC. · PI BAO, JIANXIN · 2020 to 2021
$2.2M
Developing a clinical diagnostic tool for age-related cochlear synaptopathy.R42AG078721 · NIA · GATEWAY BIOTECHNOLOGY, INC. · PI PINKL, JOSEPH · 2022 to 2024
$1.5M
NIA NIH HHS R42 AG078721NIDCD NIH HHS R44 DC018759
6 · The paper itself

Abstract

A series of articles discussing advanced diagnostics that can be used to assess noise injury and associated noise-induced hearing disorders (NIHD) was developed under the umbrella of the United States Department of Defense Hearing Center of Excellence Pharmaceutical Interventions for Hearing Loss working group. The overarching goals of the current series were to provide insight into (1) well-established and more recently developed metrics that are sensitive for detection of cochlear pathology or diagnosis of NIHD, and (2) the tools that are available for characterizing individual noise hazard as personal exposure will vary based on distance to the sound source and placement of hearing protection devices. In addition to discussing the utility of advanced diagnostics in patient care settings, the current articles discuss the selection of outcomes and end points that can be considered for use in clinical trials investigating hearing loss prevention and hearing rehabilitation.

Indexed as

DeafnessHearing Loss, Noise-InducedCochleaHumansNoise

Identifiers

PMID36732240
PMCPMC9889121
OpenAlexW4319058193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.